DECATUR, Ill. (WAND) — As reported by WAND News in July, a New Jersey pharmaceutical company will be manufacturing products in the former Akorn Pharmaceuticals facility.
Rising Pharmaceuticals will be manufacturing and packaging injectables and ophthalmic products. The plant was closed when Akorn filed for Chapter 7 bankruptcy in February with no notice given to employees.
“Six months ago, Akorn Pharmaceuticals left working families high and dry with a surprise closure of their Decatur facility. Today, I’m excited to celebrate the news that Rising Pharmaceuticals will be reopening this manufacturing facility and restoring good-paying jobs right here in our community,” said Congresswoman Nikki Budzinski (IL-13). “I look forward to meeting with Rising Pharmaceuticals’ leadership to learn more about their plans to drive economic opportunity and enhance our nation’s health care supply chain.”
Related Links
- Akorn Pharmaceuticals closes without notice to employees
- Local employers offer opportunities for laid off Akorn workers
- Millikin University opening up Spring 2023 Career Fair to recently laid off Akorn employees
- Officials weigh in on sudden Akorn layoffs
- Class action lawsuit filed against Akorn
- Akorn Pharmaceuticals plant sells for $1.2 million
The sudden closure of Akorn left more than 400 workers jobless and violated the the Illinois Worker Adjustment and Retraining Notification (WARN) Act.
Copyright 2023. WAND TV. All rights reserved.
